> top > docs > PubMed:9928552 > annotations

PubMed:9928552 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T3 0-24 D002285 denotes Ductal carcinoma in situ
T4 0-24 D002285 denotes Ductal carcinoma in situ
T9 32-38 UBERON:0000310 denotes breast
T12 100-117 D002278 denotes carcinoma in situ
T13 100-117 D002278 denotes carcinoma in situ
T15 119-123 CVCL_5552 denotes DCIS
T14 119-123 D002285 denotes DCIS
T16 119-123 D002285 denotes DCIS
T17 132-138 UBERON:0000310 denotes breast
T18 152-165 UBERON:2000098 denotes proliferation
T19 207-212 UBERON:0000058 denotes ducts
T20 232-238 UBERON:0000310 denotes breast
T22 269-286 UBERON:0005769 denotes basement membrane
T21 269-286 GO:0005604 denotes basement membrane
T26 321-331 D002277 denotes carcinomas
T27 321-331 D002277 denotes carcinomas
T29 348-352 CVCL_5552 denotes DCIS
T28 348-352 D002285 denotes DCIS
T30 348-352 D002285 denotes DCIS
T32 412-416 CVCL_5552 denotes DCIS
T31 412-416 D002285 denotes DCIS
T33 412-416 D002285 denotes DCIS
T34 439-448 D002277 denotes carcinoma
T35 439-448 D002277 denotes carcinoma
T37 474-478 CVCL_5552 denotes DCIS
T36 474-478 D002285 denotes DCIS
T38 474-478 D002285 denotes DCIS
T39 626-635 D002277 denotes carcinoma
T40 626-635 D002277 denotes carcinoma
T42 670-674 CVCL_5552 denotes DCIS
T41 670-674 D002285 denotes DCIS
T43 670-674 D002285 denotes DCIS
T44 822-828 UBERON:0000310 denotes breast
T45 822-835 D001943 denotes breast cancer
T46 822-835 D001943 denotes breast cancer
T47 876-882 UBERON:0000310 denotes breast
T48 876-889 D001943 denotes breast cancer
T49 876-889 D001943 denotes breast cancer
T50 914-924 D009362 denotes metastases
T51 914-924 D009362 denotes metastases
T53 973-977 CVCL_5552 denotes DCIS
T52 973-977 D002285 denotes DCIS
T54 973-977 D002285 denotes DCIS
T56 1117-1121 CVCL_5552 denotes DCIS
T55 1117-1121 D002285 denotes DCIS
T57 1117-1121 D002285 denotes DCIS

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T1 0-92 DRI_Background denotes Ductal carcinoma in situ of the breast: histological classification and genetic alterations.
T2 93-287 DRI_Background denotes Ductal carcinoma in situ (DCIS) of the breast represents a proliferation of malignant epithelial cells within the ducts and lobules of the breast, without invasion through the basement membrane.
T3 288-473 DRI_Background denotes It is believed that all invasive carcinomas are preceded by DCIS; however, it is not known what proportion of patients with DCIS will develop invasive carcinoma and after what interval.
T4 474-589 DRI_Outcome denotes DCIS is heterogeneous with respect to its clinical presentation, mammographic abnormalities, histology and biology.
T5 590-836 DRI_Approach denotes The risk of progression to invasive carcinoma depends on the histologic type of DCIS and the size of the lesion; in the future, the analysis of the genetic alterations may also help in predicting the risk of progression to invasive breast cancer.
T6 837-1066 DRI_Approach denotes As the risk of progression to invasive breast cancer (and the development of metastases) greatly influences the choice of treatment for DCIS, it is of importance to be able to make a reliable estimate of this risk of progression.
T7 1067-1193 DRI_Outcome denotes In this chapter, the histologic classification of DCIS and the genetic alterations that have been found to date are discussed.